Literature DB >> 16581517

The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.

Sushmita Maitra1, Rima M Kulikauskas, Heather Gavilan, Richard G Fehon.   

Abstract

The precise coordination of signals that control proliferation is a key feature of growth regulation in developing tissues . While much has been learned about the basic components of signal transduction pathways, less is known about how receptor localization, compartmentalization, and trafficking affect signaling in developing tissues. Here we examine the mechanism by which the Drosophila Neurofibromatosis 2 (NF2) tumor suppressor ortholog Merlin (Mer) and the related tumor suppressor expanded (ex) regulate proliferation and differentiation in imaginal epithelia. Merlin and Expanded are members of the FERM (Four-point one, Ezrin, Radixin, Moesin) domain superfamily, which consists of membrane-associated cytoplasmic proteins that interact with transmembrane proteins and may function as adapters that link to protein complexes and/or the cytoskeleton . We demonstrate that Merlin and Expanded function to regulate the steady-state levels of signaling and adhesion receptors and that loss of these proteins can cause hyperactivation of associated signaling pathways. In addition, pulse-chase labeling of Notch in living tissues indicates that receptor levels are upregulated at the plasma membrane in Mer; ex double mutant cells due to a defect in receptor clearance from the cell surface. We propose that these proteins control proliferation by regulating the abundance, localization, and turnover of cell-surface receptors and that misregulation of these processes may be a key component of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581517     DOI: 10.1016/j.cub.2006.02.063

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  104 in total

1.  Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway.

Authors:  Julian C Boggiano; Pamela J Vanderzalm; Richard G Fehon
Journal:  Dev Cell       Date:  2011-11-15       Impact factor: 12.270

2.  Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control.

Authors:  Yunyun Jin; Liang Dong; Yi Lu; Wenqing Wu; Qian Hao; Zhaocai Zhou; Jin Jiang; Yun Zhao; Lei Zhang
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

3.  Binary regulation of Hippo pathway by Merlin/NF2, Kibra, Lgl, and Melted specifies and maintains postmitotic neuronal fate.

Authors:  David Jukam; Claude Desplan
Journal:  Dev Cell       Date:  2011-11-03       Impact factor: 12.270

Review 4.  Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Matthias A Karajannis; Filippo G Giancotti
Journal:  EMBO Rep       Date:  2012-03       Impact factor: 8.807

Review 5.  Hippo signaling: growth control and beyond.

Authors:  Georg Halder; Randy L Johnson
Journal:  Development       Date:  2011-01       Impact factor: 6.868

6.  Hippo signaling at a glance.

Authors:  Bin Zhao; Li Li; Kun-Liang Guan
Journal:  J Cell Sci       Date:  2010-12-01       Impact factor: 5.285

7.  The cell adhesion molecule echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway.

Authors:  Tao Yue; Aiguo Tian; Jin Jiang
Journal:  Dev Cell       Date:  2012-01-25       Impact factor: 12.270

8.  Yorkie Functions at the Cell Cortex to Promote Myosin Activation in a Non-transcriptional Manner.

Authors:  Jiajie Xu; Pamela J Vanderzalm; Michael Ludwig; Ting Su; Sherzod A Tokamov; Richard G Fehon
Journal:  Dev Cell       Date:  2018-07-19       Impact factor: 12.270

9.  Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.

Authors:  Alizée Boin; Anne Couvelard; Christophe Couderc; Isabel Brito; Dan Filipescu; Michel Kalamarides; Pierre Bedossa; Leanne De Koning; Carine Danelsky; Thierry Dubois; Philippe Hupé; Daniel Louvard; Dominique Lallemand
Journal:  Neuro Oncol       Date:  2014-02-20       Impact factor: 12.300

10.  Regulation of cytoskeletal organization and junctional remodeling by the atypical cadherin Fat.

Authors:  Emily Marcinkevicius; Jennifer A Zallen
Journal:  Development       Date:  2013-01-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.